Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Parkinson Disease Psychosis”

47 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 47 results

Large-scale testing (Phase 3)Study completedNCT06068465
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
Tasly Pharmaceutical Group Co., Ltd 248
Not applicableEnded earlyNCT03152292
What this trial is testing

The INSYTE (Management of Parkinson's Disease Psychosis in Actual Practice) Study

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 764
Post-approval studies (Phase 4)Study completedNCT04292223
What this trial is testing

Open-Label Study With Pimavanserin on Activities of Daily Living in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
ACADIA Pharmaceuticals Inc. 29
Post-approval studies (Phase 4)Study completedNCT00095810
What this trial is testing

Aripiprazole in Patients With Psychosis Associated With Parkinson's Disease

Who this might be right for
Parkinson's DiseasePsychoses
Otsuka Pharmaceutical Development & Commercialization, Inc. 50
Not applicableStudy completedNCT00024622
What this trial is testing

PET Scanning in Parkinson s Disease

Who this might be right for
SchizophreniaParkinson's Disease
National Institute of Mental Health (NIMH) 502
Testing effectiveness (Phase 2)Study completedNCT03582137
What this trial is testing

Tolerability and Efficacy of Cannabidiol on Motor Symptoms in Parkinson's Disease

Who this might be right for
Parkinson Disease
University of Colorado, Denver 74
Post-approval studies (Phase 4)Looking for participantsNCT05357612
What this trial is testing

Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases

Who this might be right for
Neurodegenerative DiseasesParkinson DiseaseParkinson Disease Psychosis
Vanderbilt University Medical Center 75
Not applicableUnknownNCT04592965
What this trial is testing

Hallucinations in Parkinson's Disease

Who this might be right for
Parkinson Disease Psychosis
Olaf Blanke 40
Large-scale testing (Phase 3)Study completedNCT01174004
What this trial is testing

The Safety and Efficacy of Pimavanserin in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 199
Testing effectiveness (Phase 2)WithdrawnNCT05344365
What this trial is testing

Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Vanda Pharmaceuticals
Testing effectiveness (Phase 2)Study completedNCT02969369
What this trial is testing

Evaluate the Efficacy, Safety and Tolerability of SEP-363856 in Subjects With Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
Otsuka Pharmaceutical Development & Commercialization, Inc. 39
Not applicableStudy completedNCT02453763
What this trial is testing

In Vivo Imaging of Therapeutic Electric Current Flow

Who this might be right for
Parkinson DiseaseEpilepsyAlzheimer's Disease+4 more
University of Florida 17
Large-scale testing (Phase 3)Study completedNCT00550238
What this trial is testing

The Safety and Tolerability of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 459
Early research (Phase 1)UnknownNCT06388551
What this trial is testing

A Phase 1, SAD Study to Evaluate the Safety and Tolerability of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 60
Testing effectiveness (Phase 2)Study completedNCT00087542
What this trial is testing

Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational Drug

Who this might be right for
HallucinationsPsychosesParkinson's Disease
ACADIA Pharmaceuticals Inc. 60
Testing effectiveness (Phase 2)Looking for participantsNCT05824728
What this trial is testing

Clinical Trial Evaluating the Efficacy and Safety of AGB101 for Treatment of Parkinson's Disease Related Psychosis

Who this might be right for
Parkinson Disease Psychosis
Johns Hopkins University 30
Very early researchUnknownNCT03661125
What this trial is testing

SRC Inhibition as a Potential Target for Parkinson's Disease Psychosis

Who this might be right for
Parkinson Disease Psychosis
King's College London 30
Not applicableUnknownNCT05635266
What this trial is testing

Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives

Who this might be right for
Age-Related Macular DegenerationAllergiesAlpha-Gal Syndrome+44 more
Sanguine Biosciences 20,000
Not applicableApproved For MarketingNCT02762591
What this trial is testing

Expanded Access of Pimavanserin for Patients With PD Psychosis

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc.
Testing effectiveness (Phase 2)Study completedNCT01518309
What this trial is testing

An Open-label Safety Study of Pimavanserin in Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease Psychosis
ACADIA Pharmaceuticals Inc. 39
Next Page